Cold Spring Harbor to collaborate with Chan Zuckerberg Initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Cold Spring Harbor Laboratory announced a collaboration with the Chan Zuckerberg Initiative focused on the development and expansion of CSHL’s bioRxiv (pronounced “bio-archive”) preprint service, a free platform that enables life science researchers to quickly and easily share drafts of papers before they are published in peer-reviewed research journals.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The NHS-Galleri trial presented at ASCO was the largest, prospective, randomized trial of a multicancer early detection test (MCED) to date. The study enrolled approximately 143,000 asymptomatic adults (ages 50-77) and was the first of its kind to assess clinical utility of an MCED test for cancer screening. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login